Literature DB >> 16865350

[The trauma surgeon's role in intensive care].

C Waydhas1, A Seekamp, J A Sturm.   

Abstract

Severe injuries in patients of all ages and injuries in elderly multi-morbid subjects are a relevant medical and economic challenge. Optimal care of the polytraumatized patient can be best delivered by physicians specializing both in causal treatment of the injury or underlying disease and in intensive care. For care of critically ill injured patients, trauma surgeons with a certified specialty in intensive care medicine appear best suited. Of course, directing a surgical or trauma intensive care unit has to be full-time. Specialization of trauma surgeons (e.g., in the USA) has resulted in a considerable improvement in outcomes at least partly related to specialized trauma intensive care. Further improvement of trauma care relies on competent and innovative research not only in the fields of general intensive care, e.g., ventilation, but particularly in the complex aspects of the causality of the traumatic disease. An integrative view of the pathobiochemical, pathophysiological, and immunopathological sequelae of severe trauma under consideration of the various surgical and therapeutic strategies is the actual focus of research in surgical critical care medicine. Organ dysfunctions have to be modulated as they develop. Surgeons and trauma surgeons lead worldwide in this field of research. Obviously, competent research in polytrauma care requires competence in polytrauma intensive care.

Entities:  

Mesh:

Year:  2006        PMID: 16865350     DOI: 10.1007/s00104-006-1219-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  19 in total

1.  Multiple, progressive, or sequential systems failure. A syndrome of the 1970s.

Authors:  A E Baue
Journal:  Arch Surg       Date:  1975-07

Review 2.  [Intensive medicine criteria for operability].

Authors:  C Waydhas; S Flohe
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

3.  The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU.

Authors:  J R Border; J Hassett; J LaDuca; R Seibel; S Steinberg; B Mills; P Losi; D Border
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

4.  [Trauma center 2000. How many and which trauma centers does Europe need around the year 2000?].

Authors:  N P Haas; C von Fournier; A Tempka; N P Südkamp
Journal:  Unfallchirurg       Date:  1997-11       Impact factor: 1.000

5.  Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care.

Authors:  N L Tilney; G L Bailey; A P Morgan
Journal:  Ann Surg       Date:  1973-08       Impact factor: 12.969

6.  Development and testing of a decision tree for blunt trauma.

Authors:  W C Shoemaker; R D Corley; M Liu; H B Kram; H D Harrier; S W Williams; A W Fleming
Journal:  Crit Care Med       Date:  1988-12       Impact factor: 7.598

7.  Trauma-specific intensive care units can be cost effective and contribute to reduced hospital length of stay.

Authors:  C A Park; G McGwin; D R Smith; A K May; S M Melton; A J Taylor; L W Rue
Journal:  Am Surg       Date:  2001-07       Impact factor: 0.688

8.  Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers.

Authors:  H C Pape; M van Griensven; J Rice; A Gänsslen; F Hildebrand; S Zech; M Winny; R Lichtinghagen; C Krettek
Journal:  J Trauma       Date:  2001-06

9.  Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding.

Authors:  F A Moore; E E Moore; K A Kudsk; R O Brown; R H Bower; M J Koruda; C C Baker; A Barbul
Journal:  J Trauma       Date:  1994-10

Review 10.  Multiple organ failure. Pathophysiology and potential future therapy.

Authors:  E A Deitch
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

View more
  1 in total

1.  A comparison of the treatment of severe injuries between the former East and West German States.

Authors:  Carsten Mand; Thorben Müller; Rolf Lefering; Steffen Ruchholtz; Christian A Kühne
Journal:  Dtsch Arztebl Int       Date:  2013-03-22       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.